Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Horowski

Showing results (11-20 of 80) with videos related to

Pageof 8
Sort By:
Lancet (London, England)|August 30, 1986
Psychiatric side-effects of high-dose lisuride therapy in parkinsonismR Horowski
Journal of Neural Transmission (Vienna, Austria : 1996)|February 9, 2017
The "Madness" of Friedrich Hölderlin: an iatrogenic intoxicationR Horowski
Neurology|March 1, 1995
SchaltenbrandR Horowski
Journal of Neural Transmission (Vienna, Austria : 1996)|January 14, 2020
FG 7142: is this validated tool to study anxiety now forgotten?R Horowski
European Journal of Pharmacology|April 1, 1976
Direct dopaminergic action of lisuride hydrogen maleate, an ergot derivative, in miceR Horowski, H Wachtel
Advances in Neurology|January 1, 1984
Use of ergot derivative lisuride in Parkinson's diseaseI Suchy, R Horowski
Neurochemistry International|March 1, 1992
Clinical classification of dopaminergic effects in parkinsonismR Horowski, I Runge
Journal of Neural Transmission. Parkinson'S Disease and Dementia Section|January 1, 1991
Can we differentiate symptomatic and neuroprotective effects in parkinsonism? The dopamine agonist lisuride delays the need for levodopa therapy to a similar extent as reported for deprenylI Runge, R Horowski
Psychopharmacology|August 29, 2002
Anxiogenic, not psychotogenic, properties of the partial inverse benzodiazepine receptor agonist FG 7142 in manR Horowski, R Dorrow
Medizinische Klinik (Munich, Germany : 1983)|October 18, 2001
[A short history of beta-interferon therapy of multiple sclerosis]G Stock, R Horowski
Pageof 8

Showing results (11-20 of 80) with videos related to

Sort By:
Pageof 8
Lancet (London, England)|August 30, 1986
Psychiatric side-effects of high-dose lisuride therapy in parkinsonismR Horowski
Journal of Neural Transmission (Vienna, Austria : 1996)|February 9, 2017
The "Madness" of Friedrich Hölderlin: an iatrogenic intoxicationR Horowski
Neurology|March 1, 1995
SchaltenbrandR Horowski
Journal of Neural Transmission (Vienna, Austria : 1996)|January 14, 2020
FG 7142: is this validated tool to study anxiety now forgotten?R Horowski
European Journal of Pharmacology|April 1, 1976
Direct dopaminergic action of lisuride hydrogen maleate, an ergot derivative, in miceR Horowski, H Wachtel
Advances in Neurology|January 1, 1984
Use of ergot derivative lisuride in Parkinson's diseaseI Suchy, R Horowski
Neurochemistry International|March 1, 1992
Clinical classification of dopaminergic effects in parkinsonismR Horowski, I Runge
Journal of Neural Transmission. Parkinson'S Disease and Dementia Section|January 1, 1991
Can we differentiate symptomatic and neuroprotective effects in parkinsonism? The dopamine agonist lisuride delays the need for levodopa therapy to a similar extent as reported for deprenylI Runge, R Horowski
Psychopharmacology|August 29, 2002
Anxiogenic, not psychotogenic, properties of the partial inverse benzodiazepine receptor agonist FG 7142 in manR Horowski, R Dorrow
Medizinische Klinik (Munich, Germany : 1983)|October 18, 2001
[A short history of beta-interferon therapy of multiple sclerosis]G Stock, R Horowski
Pageof 8